natgillin/translations-raw huggingface dataset:
The vaccine protects adults and children from 2 years of age against cholera. 
Cjepivo štiti odrasle i djecu u dobi od navršene 2 godine nadalje od kolere.
The immune responses to Dukoral were not studied. 
Nisu ispitivani imunološki odgovori na Dukoral.
After the effervescent granules have been dissolved in water and the vaccine suspension has been added, the mixture should be drunk within 2 hours. 
Nakon otapanja šumećih granula u vodi i dodavanja suspenzije cjepiva, dobivenu mješavinu treba popiti u roku od 2 sata.
The effervescent granules should be dissolved in a glass of cool water, and the resulting buffer solution should be mixed with the suspension. 
Šumeće granule treba otopiti u čaši hladne vode, a dobivenu pufersku otopinu treba pomiješati sa suspenzijom.
The vaccine suspension is filled in a volume of 3 ml in vials (type I glass) with a rubber stopper (bromobutyl rubber) and a screw cap. 
Suspenzija cjepiva puni se u volumenu od 3 ml u bočice (staklo tip I) s gumenim čepom (bromobutil guma) i zatvaračem s navojem.
Do not take other medicine starting 1 hour before until 1 hour after taking the vaccine. 
Nemojte uzimati druge lijekove počevši 1 sat prije do 1 sat nakon uzimanja cjepiva.
See the package leaflet for further information. 
Pogledajte uputu o lijeku za dodatne informacije.
Drink the entire mixture within 2 hours after mixing with the buffer solution. 
Cjelokupnu mješavinu popijte unutar 2 sata nakon miješanja s puferskom otopinom.
Only half of the amount of the buffer solution should be mixed with the vaccine. 
S cjepivom treba pomiješati samo pola količine puferske otopine.
Study location 
Mjesto ispitivanja
The suspension should then be mixed with the buffer solution and drunk within 2 hours. 
Suspenziju treba zatim pomiješati s puferskom otopinom i popiti unutar 2 sata.
Following a booster dose 10-12 months after primary immunisation, the protective efficacy during the second year was 60.5% (95%CI: 28,79). 
Primjena doze docjepljivanja 10-12 mjeseci nakon primarne imunizacije rezultirala je zaštitnom djelotvornosti od 60,5% tijekom druge godine (95% CI: 28,79).
Immunisation of HIV infected subjects could result in transient increases of viral load. 
Imunizacija osoba zaraženih HIV-om može dovesti do prolaznih povećanja količine virusa u krvi.
UNIQUE IDENTIFIER 
17. JEDINSTVENI IDENTIFIKATOR
Please take this into consideration if you are on a controlled sodium diet. 
O tome trebate voditi računa ako ste na dijeti s ograničenim unosom natrija.
What you need to know before you use Dukoral Do not use Dukoral 
Što morate znati prije nego počnete primjenjivati Dukoral
Following careful benefit/risk assessment the vaccine may be administered during pregnancy and to breast-feeding women although no specific clinical studies have been performed to address this issue. 
Nakon pažljive procjene omjera koristi i rizika moguća je primjena cjepiva u trudnica i žena koje doje, iako u vezi s tim nisu provedena specifična klinička ispitivanja.
Duration of vaccine protection differed by age, lasting for 6 months in children and for 2 years in adults (see table below). 
Trajanje zaštite cjepivom razlikovalo se prema dobi te je u djece iznosilo 6 mjeseci, a u odraslih 2 godine (vidjeti tablicu u nastavku).
The vaccine acts by inducing antibodies against both the bacterial components and CTB. 
Cjepivo djeluje tako da inducira stvaranje protutijela na bakterijske komponente i CTB.
• The other ingredients in the vaccine suspension are sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride and water for injections. 
• Drugi sastojci u suspenziji cjepiva su natrijev dihidrogenfosfat, natrijev hidrogenfosfat, natrijev klorid i voda za injekcije.
Mix suspension with buffer solution before drinking. 
Suspenziju pomiješajte s puferskom otopinom prije nego što je popijete.
Blood and lymphatic system disorders: Lymphadenitis Nervous system disorders: Paraesthesia 
Poremećaji krvi i limfnog sustava: limfadenitis Poremećaji živčanog sustava: parestezije
• Nausea (feeling sick), vomiting, loss of /or poor appetite 
• mučnina, povraćanje, gubitak /ili smanjenje apetita
Follow up 
Praćenje
The safety of Dukoral was assessed in clinical trials, including both adults and children from 2 years of age, conducted in endemic and non-endemic countries for cholera and enterotoxigenic Escherichia coli (ETEC) producing heat-labile enterotoxin (LT). 
Sigurnost primjene Dukorala procijenjena je u kliničkim ispitivanjima koja su uključivala i odrasle i djecu u dobi od navršene 2 godine nadalje, provedenim u zemljama poznatim po endemskoj ili neendemskoj pojavi kolere i enterotoksične bakterije Escherichia coli (ETEC) koja proizvodi termolabilan enterotoksin (LT).
Bacterial strains of both Inaba and Ogawa serotypes and of El Tor and Classical biotypes are included in the vaccine. 
U cjepivo su uključeni bakterijski sojevi serotipova Inaba i Ogawa kao i biotip El Tor i klasični biotipovi.
6 months-5 years 
6 mjeseci - 5 godina
Dukoral contains approximately 1.1 g sodium per dose. 
Dukoral sadrži oko 1,1 g natrija po dozi.
• Swelling irritation inside the nose, and cough. 
• oticanje i nadraženost u nosu, kašalj.
It is important to use the buffer solution, as it protects the vaccine from the gastric acid. 
Važna je primjena puferske otopine jer štiti cjepivo od želučane kiseline.
Doses are to be administered at intervals of at least one week. 
Razmak između doza treba biti najmanje tjedan dana.
The vaccine is intended for oral use. 
Cjepivo je namijenjeno za peroralnu primjenu.
• Sore throat, reduced sense of taste 
• grlobolja, smanjen osjet okusa
The effervescent granules should be dissolved in approximately 150 ml of cool water to get the buffer solution. 
Šumeće granule treba otopiti u približno 150 ml hladne vode da bi se dobila puferska otopina.
Table: Protective efficacy against cholera in the Bangladesh study (per-protocol analysis) Protective efficacy, % (95% CI) Adults and children >6 year 
Tablica: Zaštitna djelotvornost protiv kolere u ispitivanju u Bangladešu (analiza po protokolu) Zaštitna djelotvornost, % (95% CI) Odrasli i djeca >6 godina Djeca 2-6 godina
How to store Dukoral 
Kako čuvati Dukoral
If more than 2 years have elapsed since the last vaccination (more than 6 months for children aged 2 to below 6 years) the primary course should be repeated. 
Ukoliko je od posljednjeg cijepljenja prošlo više od 2 godine (više od 6 mjeseci za djecu u dobi od 2 do 6 godina), potrebno je ponoviti primarno cijepljenje.
20x1 dose 
20x1 doza
Dukoral contains sodium 
Dukoral sadrži natrij
Dukoral is taken orally with bicarbonate buffer, which protects the antigens from the gastric acid. 
Dukoral se uzima peroralno s bikarbonatnim puferom koji štiti antigene od želučane kiseline.
If less than 6 months have passed since the last vaccination a single dose will renew the protection. 
Ako je prošlo manje od 6 mjeseci od posljednjeg cijepljenja, jedna doza obnovit će zaštitu.
Sodium dihydrogen phosphate dihydrate Disodium hydrogen phosphate dihydrate Sodium chloride 
natrijev dihidrogenfosfat dihidrat natrijev hidrogenfosfat dihidrat natrijev klorid voda za injekcije
The sodium hydrogen carbonate is supplied as effervescent granules, which should be dissolved in a glass of cool water (approx. 150 ml). 
Natrijev hidrogenkarbonat dolazi u obliku šumećih granula koje treba otopiti u čaši hladne vode (približno 150 ml).
Each dose of vaccine is supplied as one vial of suspension together with one sachet of effervescent granules. 
Svaka doza cjepiva dolazi u obliku jedne bočice suspenzije s jednom vrećicom šumećih granula.
For continuous protection, re-vaccination is recommended within 6 months. 
Za neprekidnu zaštitu preporučuje se docjepljivanje unutar 6 mjeseci.
The vaccine vial should be shaken gently and the vaccine suspension should then be added to the buffer solution and mixed well to get the colourless slightly opalescent oral suspension. 
Bočicu s cjepivom treba nježno protresti i zatim se suspenzija cjepiva dodaje puferskoj otopini i dobro promiješa da bi se dobila bezbojna, blago opalescentna oralna suspenzija.
For continuous protection against cholera a single booster dose is recommended within 2 years for adults and children from 6 years of age, and within 6 months for children aged 2 to below 6 years. 
Za neprekidnu zaštitu od kolere preporučuje se primjena po jedne doze docjepljivanja (booster) unutar 2 godine za odrasle i djecu u dobi od navršenih 6 godina nadalje, a unutar 6 mjeseci za djecu u dobi od 2 do 6 godina.
An exploratory analysis suggested that 2 vaccine doses seemed as effective as 3 doses in adults. 
Rezultati eksploratorne analize upućuju na jednaku učinkovitost nakon primjene 2 i 3 doze cjepiva u odraslih.
Dukoral is presented as a suspension and effervescent granules for oral suspension. 
Dukoral dolazi kao suspenzija i šumeće granule za oralnu suspenziju.
• Give the 2nd dose to the child at least 1 week after the 1st dose. 
• Dajte djetetu 2. dozu najmanje 1 tjedan nakon 1. doze.
• Fatigue/feeling tired 
• izmorenost/osjećaj umora
• Diarrhoea, stomach pain, stomach cramps, gurgling stomach, bloated stomach, stomach gas and general stomach discomfort 
• proljev, bol u trbuhu, grčevi u trbuhu, kruljenje u želucu, nadutost u trbuhu, plinovi i opća nelagoda u trbuhu,
Children 2 to below 6 years of age: half of the buffer solution is poured away and the remaining part (approx. 75 ml) is mixed with the entire contents of the vaccine vial. 
Djeca u dobi od 2 do 6 godina: pola količine puferske otopine se odlije, a preostali se dio (oko 75 ml) pomiješa s cjelokupnim sadržajem bočice s cjepivom.
How to use Dukoral 
Kako primjenjivati Dukoral
Children 2 to below 6 years of age: half of the buffer solution is poured away and the remaining part (approx. 75 ml) is mixed with the entire contents of the vial. 
Djeca u dobi od 2 do 6 godina: odlije se pola količine puferske otopine, a preostali dio (oko 75 ml) se pomiješa s cjelokupnim sadržajem iz bočice.
Children of 2 to below 6 years of age: The primary vaccination is 3 doses taken orally (by mouth) at least 1 week (up to 6 weeks) apart. 
Djeca u dobi od 2 do 6 godina: primarno cijepljenje su 3 doze uzete peroralno (na usta) u razmaku od najmanje 1 tjedna (do 6 tjedana).
• Sweating, shivering 
• znojenje, drhtanje
Adults and children from 6 years of age: The primary vaccination is 2 doses taken orally (by mouth) at least 1 week (up to 6 weeks) apart. 
Odrasli i djeca u dobi od navršenih 6 godina nadalje: primarno cijepljenje je 2 doze uzete peroralno (na usta) u razmaku od najmanje 1 tjedna (do 6 tjedana).
• Swelling of the lymph glands 
• oticanje limfnih žlijezda
Preliminary results from a clinical study including a limited number of volunteers showed no interaction with the antibody response to Dukoral when a live oral vaccine (enterocapsules) against typhoid was given simultaneously with Dukoral. 
Preliminarni rezultati kliničkog ispitivanja provedenog na ograničenom broju dobrovoljaca pokazali su da istodobna primjena cjepiva Dukoral i živog peroralnog cjepiva (enterokapsule) protiv tifusa ne utječe na stvaranje protutijela na Dukoral.
The immune response to live typhoid vaccine was not investigated in this study. 
U ovom ispitivanju nije ispitivan imunološki odgovor na živo cjepivo protiv tifusa.
Valneva Sweden AB S-105 21 Stockholm Sweden infodukoral@valneva.com 
Valneva Sweden AB S-105 21 Stockholm Švedska infodukoral@valneva.com
No clinical data on protective efficacy of Dukoral against cholera after administration of booster doses are available. 
Nema kliničkih podataka o zaštitnoj djelotvornosti Dukorala protiv kolere nakon primjene booster doze.
The effervescent granules are white with a raspberry flavour and are supplied in a sachet. 
Šumeće granule su bijele boje s aromom maline i pakirane u vrećice.
In the second trial, conducted in Peru and enrolling military recruits, the short-term protective efficacy against cholera after 2 vaccine doses was 85% (95%CI: 36, 97, per-protocol analysis). 
U drugom ispitivanju, koje je uključivalo vojne regrute u Peruu, kratkotrajna zaštitna djelotvornost protiv kolere nakon primjene 2 doze cjepiva iznosila je 85% (95% CI: 36, 97, analiza po protokolu).
To be used with DUKORAL. 
Mora se primjenjivati uz DUKORAL.
Other side effects: Uncommon side effects (may affect up to 1 in a 100 people) 
Druge nuspojave: Manje česte nuspojave (mogu se javiti u do 1 na 100 ljudi)
For continuous protection, re-vaccination is recommended within 2 years. 
Za neprekidnu zaštitu, preporučuje se docjepljivanje unutar 2 godine.
In the longitudinal cohort-analysis conducted during the mass-vaccination campaign in Zanzibar, protective effectiveness after 2 doses of Dukoral was 79% (95% CI, 47, 92) for a follow-up period of 15 months. 
U longitudinalnoj kohortnoj analizi provedenoj tijekom kampanje masovnog cijepljenja u Zanzibaru, zaštitna učinkovitost nakon 2 doze Dukorala bila je 79% (95% CI, 47, 92) u 15-mjesečnom razdoblju praćenja.
Loss of /or poor appetite Very rare Dehydration 
Poremećaji metabolizma i prehrane Rijetko gubitak /ili smanjenje apetita Vrlo rijetko dehidracija
However, immunological and duration of protection data suggest that if up to 2 years have elapsed since the last vaccination for adults and up to 6 months for children aged 2 to below 6 years a single booster dose should be given. 
Međutim, imunološki podaci i podaci o trajanju zaštite pokazuju da treba dati samo jednu dodatnu dozu ukoliko je proteklo do 2 godine od zadnje primjene cjepiva za odrasle i do 6 mjeseci za djecu u dobi od 2 do 6 godina.
For children of 2 to below6 years: pour away half of the buffer solution. 
Za djecu u dobi od 2 do 6 godina: odlijte pola količine puferske otopine.
Very rare side effects (may affect up to 1 in a 10,000 people) 
Vrlo rijetke nuspojave (mogu se javiti u do 1 na 10 000 ljudi)
No established immunological correlates of protection against cholera after oral vaccination have been identified. 
Nije utvrđena imunološka korelacija zaštite od kolere nakon oralne primjene cjepiva.
Vibrio cholerae O1 Inaba, classical biotype (heat inactivated) 
Vibrio cholerae O1 Inaba, klasični biotip (inaktiviran toplinom)
Musculoskeletal and connective tissue disorders Very rare Joint pain 
Poremećaji mišićno-koštanog sustava i vezivnog tkiva Vrlo rijetko bol u zglobovima
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS DUKORAL, vial label 1 dose 
PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE DUKORAL, naljepnica bočice s 1 dozom
• Take the 1st dose no later than 2 weeks before you leave for your trip. 
• Uzmite 1. dozu ne kasnije od 2 tjedna prije Vašeg odlaska na putovanje.
If more than 6 weeks have elapsed between doses, the primary immunisation course should be re-started. 
Ukoliko između primjene pojedine doze cjepiva protekne više od 6 tjedana, treba ponovno započeti program primarne imunizacije.
If more than 6 weeks have passed, contact your doctor, pharmacist or nurse. 
Ako je proteklo više od 6 tjedana, obratite se svom liječniku, ljekarniku ili medicinskoj sestri.
The effervescent granules are filled in an amount of 5.6 g in sachets with an inner layer of polyester/LD-polyethylene and an outer layer of aluminium/LD-polyethylene. 
Šumeće granule pakirane su u količini od 5,6 g u vrećice s unutarnjim slojem od poliestera/LD
Shake the Dukoral® suspension vial (1 vial = 1 dose). 
2. Protresite bočicu suspenzije Dukoral® (1 bočica = 1 doza).
In the Bangladesh field trial, protective efficacy of Dukoral in the overall population was 85% (95%CI: 56, 95, per-protocol analysis) for the initial 6 months of follow-up. 
Tijekom terenskog ispitivanja provedenog u Bangladešu zabilježena je 85%-tna zaštitna djelotvornost Dukorala u sveukupnoj populaciji (95%CI: 56, 95, analiza po protokolu) u prvih 6 mjeseci praćenja.
Vaccine protective efficacy has not been studied. 
Nisu provedena ispitivanja zaštitne djelotvornosti cjepiva.
Dukoral is an oral vaccine against cholera that stimulates the immunological defence in the gut. 
Dukoral je cjepivo protiv kolere za primjenu kroz usta koje stimulira imunološku obranu u crijevima.
Cholera vaccine (inactivated, oral) 
Cjepivo protiv kolere (inaktivirano, oralno)
Rare side effects (may affect up to 1 in a 1,000 people) 
Rijetke nuspojave (mogu se javiti u do 1 na 1000 ljudi)
To prepare the buffer solution,dissolve the effervescent granules in a glass of cool water (approx. 150 ml) by gently stirring. 
Za pripremu puferske otopine otopite šumeće granule u čaši hladne vode (približno 150 ml)
Protective efficacy of Dukoral against cholera has not been studied following repeated booster vaccination. 
Zaštitna djelotvornost Dukorala protiv kolere nakon ponovljenog booster cijepljenja nije ispitivana.
• Give the 1st dose to the child no later than 3 weeks before you leave for your trip. 
• Dajte djetetu 1. dozu ne kasnije od 3 tjedana prije odlaska na putovanje.
• Take the 2nd dose at least 1 week after the 1st dose and at least 1 week before your trip. 
• Uzmite 2. dozu najmanje 1 tjedan nakon 1. doze i najmanje 1 tjedan prije Vašeg putovanja.
- granules for oral suspension in a sachet :: 
- granule za oralnu suspenziju u vrećici:
• Give the 3rd dose at least one week after the 2nd dose and at least one week before your trip. 
• Dajte 3. dozu najmanje 1 tjedan nakon 2. doze i najmanje 1 tjedan prije vašeg putovanja.
In the case-control study conducted during the mass vaccination campaign in Mozambique, protective effectiveness of 2 doses of Dukoral was 84% (95% CI: 43, 95, per-protocol analysis; p=0.005) for the initial 5 months of follow-up. 
U „case-control“ ispitivanju (istraživanju parova) provedenom tijekom kampanje masovnog cijepljenja u Mozambiku, zaštitna učinkovitost 2 doze Dukorala bila je 84% (95% CI: 43, 95, analiza po protokolu; p=0,005) u početnih 5 mjeseci praćenja.
In subjects infected with HIV, limited data are available on immunogenicity and safety of the vaccine. 
Malo je podataka o imunogenosti i sigurnosti cjepiva u osoba zaraženih HIV-om.
If you take the doses less than one week apart, contact your doctor, pharmacist or nurse. 
Ako uzmete doze s razmakom manjim od tjedan dana, obratite se svom liječniku, ljekarniku ili medicinskoj sestri.
− Recombinant cholera toxin B subunit (rCTB) 1 mg 
Rekombinantna B podjedinica toksina kolere (rCTB) 1 mg.
MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE 
PROIZVOĐAČI BIOLOŠKIH DJELATNIH TVARI I PROIZVOĐAČ ODGOVORAN
PARTICULARS TO APPEAR ON THE OUTER PACKAGING DUKORAL - 1 dose package, 2x1 dose package, 20x1 dose package (outer sleeve) 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU DUKORAL - pakiranje s 1 dozom, pakiranje s 2x1 dozom, pakiranje s 20x1 dozom (vanjski omot)
Nervous system disorders Uncommon Headache Rare 
Poremećaji živčanog sustava Manje često glavobolja
If you have taken more than one dose at one time, please contact your doctor, pharmacist or nurse. 
Ako ste uzeli više od jedne doze odjednom, molimo obratite se svom liječniku, ljekarniku ili medicinskoj sestri.
The suspensionsupplied in a single-dose glass vial is a whitish suspension.. Each vial comes with one sachet package that contains white effervescent granules of sodium hydrogen carbonate. 
Jedna bočica dolazi uz jednu vrećicu koja sadrži bijele šumeće granule natrijeva hidrogenkarbonata.
If more than 6 months have passed since the last vaccination, the primary vaccination (3 doses) should be repeated. 
Ako je od posljednjeg cijepljenja prošlo više od 6 mjeseci, potrebno je ponoviti primarno cijepljenje (3 doze).
The standard primary course of vaccination with Dukoral against cholera consists of 2 doses for adults and children from 6 years of age. 
Standardno primarno cijepljenje Dukoralom protiv kolere kod odraslih i djece u dobi od navršenih 6 godina nadalje, provodi se s 2 doze cjepiva.
Respiratory, thoracic and mediastinal disorders: Dyspnoea, increased sputum Gastrointestinal disorders: Flatulence 
Poremećaji dišnog sustava, prsišta i sredoprsja: dispneja, povećano stvaranje iskašljaja Poremećaji probavnog sustava: flatulencija
Valneva Sweden AB 105 21 Stockholm, Sweden 
Valneva Sweden AB 105 21 Stockholm, Švedska
Valneva Sweden AB SE-105 21 Stockholm Sweden 
Valneva Sweden AB SE-105 21 Stockholm Švedska
− 31.25x109 bacteria* of each of the following V. cholerae O1 strains: Inaba classical biotype (heat inactivated), Inaba El Tor biotype (formalin inactivated), Ogawa classical biotype (heat inactivated), Ogawa classical biotype (formalin inactivated). 
− 31,25x109 bakterija* svakog od sljedećih sojeva bakterije V. cholerae O1: Inaba klasični biotip (inaktiviran toplinom), Inaba El Tor biotip (inaktiviran formalinom), Ogawa klasični biotip (inaktiviran toplinom), Ogawa klasični biotip (inaktiviran formalinom).
Oral administration of other medicinal products should be avoided within 1 hour before and 1 hour after administration of Dukoral. 
Peroralnu primjenu drugih lijekova treba izbjegavati 1 sat prije i 1 sat nakon uzimanja Dukorala.
If more than 2 years have passed since you had the last vaccine dose, the primary vaccination (2 doses) should be repeated. 
Ako je od posljednje doze cjepiva prošlo više od 2 godine, potrebno je ponoviti primarno cijepljenje (2 doze).
31.25x109 bacteria* of each of the following V. cholerae O1 strains: Inaba classical biotype (heat inactivated), Inaba El Tor biotype (formalin inactivated), Ogawa classical biotype (heat inactivated), Ogawa classical biotype (formalin inactivated). 
31,25x109 bakterija* svakog od sljedećih sojeva bakterije V. cholerae O1: Inaba klasični biotip (inaktiviran toplinom), Inaba El Tor biotip (inaktiviran formalinom), Ogawa klasični biotip (inaktiviran toplinom), Ogawa klasični biotip (inaktiviran formalinom).
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING DUKORAL - 20x1 dose package (inner carton for 20 sodium hydrogen carbonate sachets) 
DUKORAL - pakiranje s 20x1 dozom (unutarnja kutija za 20 vrećica natrijeva hidrogenkarbonata)
The suspension is a whitish suspension supplied in a vial. 
Suspenzija je bjelkasta suspenzija u bočici.
No clinical efficacy data has been generated on repeat booster dosing. 
Nema podataka o kliničkoj djelotvornosti ponavljanih primjena booster doza.
Oral administration of other vaccines and medicinal products should be avoided 1 hour before and 1 hour after administration of Dukoral. 
Peroralnu primjenu drugih cjepiva i lijekova treba izbjegavati 1 sat prije i 1 sat nakon primjene Dukorala.
Pour the content of the Dukoral® suspension vial into the glass of buffer solution (see 1). 
Ulijte sadržaj bočice sa suspenzijom Dukoral® u čašu s puferskom otopinom (pogledajte korak
Pack sizes: 1x1 dose, 2x1 dose, 20x1 dose Not all pack sizes may be marketed. 
Veličina pakiranja: 1x1 doza, 2x1 doza, 20x1 doza
No other vaccines/ medicinal products, including oral polio vaccine and antimalarials, have been given simultaneously with Dukoral in clinical studies. 
U kliničkim ispitivanjima nije ispitana istodobna primjena Dukorala s drugim cjepivima/lijekovima, uključujući peroralno cjepivo protiv poliomijelitisa i lijekove protiv malarije.
The most frequently reported adverse reactions, such as gastrointestinal symptoms including abdominal pain, diarrhoea, loose stools, nausea and vomiting, occurred at similar frequencies in vaccine and placebo groups. 
Najčešće prijavljivane nuspojave kao što su gastrointestinalni simptomi, uključujući bol u abdomenu,
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING DUKORAL - 20x1 dose package (inner carton for 20 vaccine vials) 
PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU DUKORAL - pakiranje s 20x1 dozom (unutarnja kutija za 20 bočica cjepiva)
• The effervescent granules contain sodium hydrogen carbonate, citric acid, sodium carbonate, saccharin sodium, sodium citrate and raspberry flavour. 
• Šumeće granule sadrže natrijev hidrogenkarbonat, citratnu kiselinu, natrijev karbonat,
Sodium carbonate, anhydrous Saccharin sodium Sodium citrate 
natrijev hidrogenkarbonat citratna kiselina natrijev karbonat, bezvodni saharinnatrij natrijev citrat aroma maline
Food and drink should be avoided 1 hour before and 1 hour after vaccination. 
Uzimanje hrane i pića treba izbjegavati 1 sat prije i 1 sat nakon primjene cjepiva.